BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34321181)

  • 1. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
    Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
    Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
    Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
    J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
    Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorhexidine-impregnated gel dressing compared with transparent polyurethane dressing in the prevention of catheter-related infections in critically ill adult patients: A pilot randomised controlled trial.
    Margatho AS; Ciol MA; Hoffman JM; Dos Reis PED; Furuya RK; Lima DAFS; Basile-Filho A; Silveira RCCP
    Aust Crit Care; 2019 Nov; 32(6):471-478. PubMed ID: 30558968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
    Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
    Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovation in Central Venous Access Device Security: A Pilot Randomized Controlled Trial in Pediatric Critical Care.
    Ullman AJ; Long D; Williams T; Pearson K; Mihala G; Mattke AC; Macfarlane F; Rickard CM
    Pediatr Crit Care Med; 2019 Oct; 20(10):e480-e488. PubMed ID: 31274778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
    Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
    Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
    Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
    BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dressings and securement devices for central venous catheters (CVC).
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010367. PubMed ID: 26358142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
    Gilbert RE; Mok Q; Dwan K; Harron K; Moitt T; Millar M; Ramnarayan P; Tibby SM; Hughes D; Gamble C;
    Lancet; 2016 Apr; 387(10029):1732-42. PubMed ID: 26946925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot randomised controlled trial of dressing and securement methods to prevent arterial catheter failure in intensive care.
    Larsen EN; Corley A; Mitchell M; Lye I; Powell M; Tom S; Mihala G; Ullman AJ; Gibson V; Marsh N; Kleidon TM; Rapchuk IL; Rickard CM
    Aust Crit Care; 2021 Jan; 34(1):38-46. PubMed ID: 32698986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central venous Access device SeCurement And Dressing Effectiveness (CASCADE) in paediatrics: protocol for pilot randomised controlled trials.
    Ullman AJ; Kleidon T; Gibson V; Long DA; Williams T; McBride CA; Hallahan A; Mihala G; Cooke M; Rickard CM
    BMJ Open; 2016 Jun; 6(6):e011197. PubMed ID: 27259529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimising central line-associated bloodstream infection rate in inserting central venous catheters in the adult intensive care units.
    Hina HR; McDowell JRS
    J Clin Nurs; 2017 Dec; 26(23-24):3962-3973. PubMed ID: 28334482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
    Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
    JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial.
    Ullman AJ; Kleidon T; Gibson V; McBride CA; Mihala G; Cooke M; Rickard CM
    BMC Cancer; 2017 Aug; 17(1):595. PubMed ID: 28854967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial.
    Ruschulte H; Franke M; Gastmeier P; Zenz S; Mahr KH; Buchholz S; Hertenstein B; Hecker H; Piepenbrock S
    Ann Hematol; 2009 Mar; 88(3):267-72. PubMed ID: 18679683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
    Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
    Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.